Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × tocilizumab × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 9 Lymphoma, Non-Hodgkin 6 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Craniopharyngioma 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Nasopharyngeal Neoplasms 1 Mesothelioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Immune-related Adverse Events 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Cytokine Release Syndrome 1 Carcinoma, Transitional Cell 1 Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡